Home
Farallon Capital Partners reported a 5.2% stake in BridgeBio Pharma BBIO · 10,226,063 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.2%
- Last report
- First report
- Shares held
- 10,226,063 sh
- Class
- Common Stock, par value $0.001 per share (the "Shares")
- Event date
- 26/05/22
- Filed
- 26/05/29
First 5%+ report · 5.2% stake
BridgeBio Pharma trades, last 26 weeks
What else happened in BridgeBio Pharma around then
Filed or reported within 30 days of the trade day · 04/22~06/21Farallon Capital Partners's other 5% stake reports
- Farallon Capital Partners
5% stakeInflaRx
5% stakeInflaRx
IFRX
5.1% stake
7,500,000 sh
5.1% stake
Filed 05/14
- Farallon Capital Partners
5% stakeTyra Biosciences
5% stakeTyra Biosciences
TYRA
6.6% stake
3,580,818 sh
6.6% stake
Filed 05/12
- Farallon Capital Partners
5% stakeBeta Bionics
5% stakeBeta Bionics
BBNX
8.1% stake
3,607,920 sh
8.1% stake
Filed 05/12
- Farallon Capital Partners
5% stakeGrail
5% stakeGrail
GRAL
7.8% stake
3,253,684 sh
7.8% stake
Filed 05/11
- Farallon Capital Partners
5% stakeTango Therapeutics
5% stakeTango Therapeutics
TNGX
7.8% stake
11,257,203 sh
7.8% stake
Filed 05/11
